478 related articles for article (PubMed ID: 32975234)
1. Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT
Wang J; Qin C; Zhong C; Wen Y; Ke S; Liao BO
J Biosci; 2020; 45():. PubMed ID: 32975234
[TBL] [Abstract][Full Text] [Related]
2. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma.
Peng L; Liu YH; Nie S; Gao M
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8367-8376. PubMed ID: 32894543
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
5. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
6. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA cancer susceptibility candidate 2 regulates the function of human fibroblast-like synoviocytes via the microRNA-18a-5p/B-cell translocation gene 3 signaling axis in rheumatoid arthritis.
Ye Z; Wei L; Yin X; Li H; Qin G; Li S; Peng T; Liu B; Zhao S; Zhuo Q
Bioengineered; 2022 Feb; 13(2):3240-3250. PubMed ID: 35045800
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
9. Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1.
Zhang Y; Qian W; Feng F; Cao Q; Li Y; Hou Y; Zhang L; Fan J
Oncol Res; 2019 Feb; 27(3):371-377. PubMed ID: 29422114
[TBL] [Abstract][Full Text] [Related]
10. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
11. NR2C2-uORF targeting UCA1-miR-627-5p-NR2C2 feedback loop to regulate the malignant behaviors of glioma cells.
Fan Z; Zheng J; Xue Y; Liu X; Wang D; Yang C; Ma J; Liu L; Ruan X; Wang Z; Liu Y
Cell Death Dis; 2018 Dec; 9(12):1165. PubMed ID: 30518750
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1.
Li Q; Cheng Q; Chen Z; Peng R; Chen R; Ma Z; Wan X; Liu J; Meng M; Peng Z; Jiang B
Oncol Rep; 2016 Feb; 35(2):1125-34. PubMed ID: 26717894
[TBL] [Abstract][Full Text] [Related]
13. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
Liu B; Li X; Li C; Xu R; Sun X
Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
[TBL] [Abstract][Full Text] [Related]
14. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-18a-5p promotes EMT and metastasis of NPC cells via targeting BTG3 and activating the Wnt/β-catenin signaling pathway.
Zhong Q; Nie Q; Wu R; Huang Y
Cell Cycle; 2023 Jul; 22(13):1544-1562. PubMed ID: 37287276
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
Chen XB; Li W; Chu AX
J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
[TBL] [Abstract][Full Text] [Related]
18. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
[TBL] [Abstract][Full Text] [Related]
19. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
Xu DF; Wang LS; Zhou JH
Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
[TBL] [Abstract][Full Text] [Related]
20. lncRNA CASC2 suppresses the growth of hemangioma cells by regulating miR-18a-5p/FBXL3 axis.
Dai YX; Qiu MK; Wang SQ; Pan C; Wang Y; Ou JM
J Biol Regul Homeost Agents; 2020; 34(1):49-56. PubMed ID: 32138500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]